Abiomed Statistics

Share Statistics

Abiomed has 45.09M shares outstanding. The number of shares has increased by -0.45% in one year.

Shares Outstanding	45.09M
Shares Change (YoY)	-0.45%
Shares Change (QoQ)	-1.04%
Owned by Institutions (%)	n/a
Shares Floating	44.56M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 254.54K, so 0% of the outstanding shares have been sold short.

Short Interest	254.54K
Short % of Shares Out	n/a
Short % of Float	0.58%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 110.28 and the forward PE ratio is null. Abiomed's PEG ratio is -2.76.

PE Ratio	110.28
Forward PE	n/a
PS Ratio	14.59
Forward PS	n/a
PB Ratio	10.01
P/FCF Ratio	60.3
PEG Ratio	-2.76

Financial Ratio History

Enterprise Valuation

Abiomed has an Enterprise Value (EV) of 14.92B.

EV / Sales	14.46
EV / EBITDA	37.23
EV / EBIT	52.28
EV / FCF	59.77

Financial Position

The company has a current ratio of 7.05, with a Debt / Equity ratio of 0.

Current Ratio	7.05
Quick Ratio	6.37
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	7.48

Financial Efficiency

Return on Equity is 9.08% and Return on Invested Capital is 17.39%.

Return on Equity	9.08%
Return on Assets	8.16%
Return on Invested Capital	17.39%
Revenue Per Employee	$515.1K
Profits Per Employee	$68.15K
Employee Count	2,003
Asset Turnover	0.62
Inventory Turnover	2

Taxes

Income Tax	54.05M
Effective Tax Rate	28.37%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Abiomed's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	348.85
200-Day Moving Average	292
Relative Strength Index (RSI)	76.23
Average Volume (20 Days)	1,703,123

Income Statement

In the last 12 months, Abiomed had revenue of 1.03B and earned 136.5M in profits. Earnings per share was 3.

Revenue	1.03B
Gross Profit	843.6M
Operating Income	372.69M
Net Income	136.5M
EBITDA	400.78M
EBIT	472.37M
Earnings Per Share (EPS)	3

Full Income Statement

Balance Sheet

The company has 132.82M in cash and 0 in debt, giving a net cash position of 132.82M.

Cash & Cash Equivalents	132.82M
Total Debt	n/a
Net Cash	n/a
Retained Earnings	964.51M
Total Assets	1.7B
Working Capital	928.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 285.39M and capital expenditures -35.76M, giving a free cash flow of 249.63M.

Operating Cash Flow	285.39M
Capital Expenditures	-35.76M
Free Cash Flow	249.63M
FCF Per Share	5.49

Full Cash Flow Statement

Margins

Gross margin is 81.76%, with operating and profit margins of 36.12% and 13.23%.

Gross Margin	81.76%
Operating Margin	36.12%
Pretax Margin	18.47%
Profit Margin	13.23%
EBITDA Margin	38.84%
EBIT Margin	36.12%
FCF Margin	24.19%

Dividends & Yields

ABMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.91%
FCF Yield	1.66%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ABMD.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$15
Lynch Upside	-96.06%
Graham Number	47.28
Graham Upside	-87.59%

Stock Splits

The last stock split was on Oct 2, 2000. It was a forward split with a ratio of 2:1.

Last Split Date	Oct 2, 2000
Split Type	forward
Split Ratio	2:1

Scores

Altman Z-Score	68.48
Piotroski F-Score	5

Abiomed Inc. (ABMD)